Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis
Posted by
www.biotecnika.org
Drug major Glenmark Pharma said it has received final approval from
the US health regulator for Dimethyl Fumarate delayed-release
capsules, used for the treatment of relapsing forms of multiple
sclerosis in adults.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-to-market-drug-for-relapsing-multiple-sclerosis/articleshow/78527839.cms
Subscribe to:
Post Comments (Atom)
Post a Comment